Business
CSL (ASX:CSL) share price lower amid reported mRNA vaccine delays
Image source: Getty Images
The CSL Limited (ASX: CSL) share price is falling amid reports Australia might not be capable of producing mRNA vaccines until 2023.
Right now, shares in CSL are swapping hands for $276.09 – 1.33% less than yesterday’s closing price.
The fall…
Continue Reading
-
General17 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News24 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General22 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News24 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026